Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

RhoGEF p115_Lsc Inhibitors

RhoGEF p115_Lsc inhibitors comprise a diverse range of chemical compounds designed to selectively modulate the activity of RhoGEF p115_Lsc. These inhibitors exert their effects through various mechanisms, either by directly targeting RhoGEF p115_Lsc or by influencing the signaling pathways associated with Rho GTPases, which are integral to RhoGEF p115_Lsc regulation. Y-27632, for instance, directly inhibits RhoGEF p115_Lsc by targeting Rho-associated protein kinase (ROCK), a downstream effector of Rho. This disruption of ROCK-mediated signaling influences actin cytoskeleton dynamics and cellular processes regulated by RhoGEF p115_Lsc, such as cell migration and adhesion. CCG-222740, CT04, Rhosin, and Rhosin hydrobromide are small molecule inhibitors that potentially modulate RhoGEF p115_Lsc by interfering with Rho GTPase signaling pathways. These compounds specifically impact Rho signaling cascades, leading to downstream modulation of RhoGEF p115_Lsc activity and affecting cellular processes like cell motility and cytoskeletal rearrangements.

NSC23766, ML141, Rhosin hydrochloride, and Rhodamine-conjugated C3 exoenzyme target individual members of the Rho GTPase family, such as Rac1 and Cdc42. By selectively inhibiting these GTPases, these compounds potentially modulate signaling pathways associated with RhoGEF p115_Lsc, leading to downstream effects on RhoGEF p115_Lsc activity and influencing cellular processes like cell migration and adhesion. LIM kinase inhibitor 1 (LIMKi1) indirectly modulates RhoGEF p115_Lsc by targeting LIM kinase, a downstream effector of Rho. This indirect modulation influences actin cytoskeleton dynamics and cellular processes dependent on RhoGEF p115_Lsc, such as cell motility and adhesion. Secramine A, while not directly targeting RhoGEF p115_Lsc, impacts membrane trafficking and endocytosis, potentially influencing RhoGEF p115_Lsc activity through modulation of cellular processes. Its effects on membrane dynamics can lead to downstream effects on RhoGEF p115_Lsc, affecting cellular processes like cell migration and cytoskeletal organization. In summary, these inhibitors collectively provide a robust toolkit for researchers to explore the specific functions of RhoGEF p115_Lsc in various cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Y-27632 inhibits RhoGEF p115_Lsc by specifically targeting Rho-associated protein kinase (ROCK), a downstream effector of Rho. It disrupts ROCK-mediated signaling, influencing actin cytoskeleton dynamics and cellular processes dependent on RhoGEF p115_Lsc, such as cell migration and adhesion.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

ML141 is a selective inhibitor of Cdc42, another member of the Rho GTPase family. By targeting Cdc42, it potentially modulates signaling pathways associated with RhoGEF p115_Lsc, leading to downstream effects on RhoGEF p115_Lsc activity. The compound can impact cellular processes such as cell migration and cytoskeletal organization regulated by RhoGEF p115_Lsc.

Rhosin

1173671-63-0sc-507401
25 mg
$555.00
(0)

Rhosin hydrobromide is a salt form of Rhosin, a small molecule inhibitor targeting Rho GTPases, including those connected to RhoGEF p115_Lsc. By interfering with Rho signaling pathways, it can influence the activity of RhoGEF p115_Lsc, impacting cellular processes like cell migration and cytoskeletal dynamics.